Bisoprolol reduces cardiac death and myocardial infarction in high-risk patients as long as 2 years after successful major vascular surgery

Don Poldermans, E. Boersma, J. J. Bax, I. R. Thomson, B. Paelinck, L. L M Van De Ven, M. G. Scheffer, G. Trocino, C. Vigna, H. F. Baars, H. Van Urk, J. R T C Roelandt

Research output: Contribution to journalArticle

175 Citations (Scopus)

Abstract

Aim: To assess the long-term cardioprotective effect of bisoprolol in a randomized high-risk population after successful major vascular surgery. High-risk patients were defined by the presence of one or more cardiac risk factor(s) and a dobutamine echocardiography test positive for ischaemia. Methods: 1351 patients were screened prior to surgery, 846 patients had one or more risk factor(s), and 173 of these patients also had ischaemia during dobutamine echocardiography. One hundred and twelve patients could be randomized for additional bisoprolol therapy or standard care. Eleven patients died in the peri-operative period (up to 1 month after surgery). Randomized patients continued bisoprolol or standard care after surgery. During follow-up of 101 survivors (median 22 months, range 11-30) cardiac death or myocardial infarction was noted. No patient was lost during follow-up. Results: The incidence of cardiac events during follow-up in the bisoprolol group was 12% vs 32% in the standard care group (P=0.025). Cardiac death occurred in 15 patients, nine patients in the standard care and in six in the bisoprolol group; myocardial infarction occurred in six patients, five in the standard care and one in the bisoprolol group. The odds ratio for cardiac death or myocardial infarction after surgery in high-risk patients with additional bisoprolol therapy was 0.30 (0.11-0.83). Conclusions: Bisoprolol significantly reduced long-term cardiac death and myocardial infarction in high-risk patients after successful major cardiac vascular surgery.

Original languageEnglish
Pages (from-to)1353-1358
Number of pages6
JournalEuropean Heart Journal
Volume22
Issue number15
DOIs
Publication statusPublished - 2001

Fingerprint

Bisoprolol
Blood Vessels
Myocardial Infarction
Dobutamine
Echocardiography
Ischemia

Keywords

  • Beta-blockers
  • High-risk patients
  • Long-term follow-up
  • Major vascular surgery

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Poldermans, D., Boersma, E., Bax, J. J., Thomson, I. R., Paelinck, B., Van De Ven, L. L. M., ... Roelandt, J. R. T. C. (2001). Bisoprolol reduces cardiac death and myocardial infarction in high-risk patients as long as 2 years after successful major vascular surgery. European Heart Journal, 22(15), 1353-1358. https://doi.org/10.1053/euhj.2000.2555

Bisoprolol reduces cardiac death and myocardial infarction in high-risk patients as long as 2 years after successful major vascular surgery. / Poldermans, Don; Boersma, E.; Bax, J. J.; Thomson, I. R.; Paelinck, B.; Van De Ven, L. L M; Scheffer, M. G.; Trocino, G.; Vigna, C.; Baars, H. F.; Van Urk, H.; Roelandt, J. R T C.

In: European Heart Journal, Vol. 22, No. 15, 2001, p. 1353-1358.

Research output: Contribution to journalArticle

Poldermans, D, Boersma, E, Bax, JJ, Thomson, IR, Paelinck, B, Van De Ven, LLM, Scheffer, MG, Trocino, G, Vigna, C, Baars, HF, Van Urk, H & Roelandt, JRTC 2001, 'Bisoprolol reduces cardiac death and myocardial infarction in high-risk patients as long as 2 years after successful major vascular surgery', European Heart Journal, vol. 22, no. 15, pp. 1353-1358. https://doi.org/10.1053/euhj.2000.2555
Poldermans, Don ; Boersma, E. ; Bax, J. J. ; Thomson, I. R. ; Paelinck, B. ; Van De Ven, L. L M ; Scheffer, M. G. ; Trocino, G. ; Vigna, C. ; Baars, H. F. ; Van Urk, H. ; Roelandt, J. R T C. / Bisoprolol reduces cardiac death and myocardial infarction in high-risk patients as long as 2 years after successful major vascular surgery. In: European Heart Journal. 2001 ; Vol. 22, No. 15. pp. 1353-1358.
@article{4db3bf782f284d18aadaa9fc9b10390a,
title = "Bisoprolol reduces cardiac death and myocardial infarction in high-risk patients as long as 2 years after successful major vascular surgery",
abstract = "Aim: To assess the long-term cardioprotective effect of bisoprolol in a randomized high-risk population after successful major vascular surgery. High-risk patients were defined by the presence of one or more cardiac risk factor(s) and a dobutamine echocardiography test positive for ischaemia. Methods: 1351 patients were screened prior to surgery, 846 patients had one or more risk factor(s), and 173 of these patients also had ischaemia during dobutamine echocardiography. One hundred and twelve patients could be randomized for additional bisoprolol therapy or standard care. Eleven patients died in the peri-operative period (up to 1 month after surgery). Randomized patients continued bisoprolol or standard care after surgery. During follow-up of 101 survivors (median 22 months, range 11-30) cardiac death or myocardial infarction was noted. No patient was lost during follow-up. Results: The incidence of cardiac events during follow-up in the bisoprolol group was 12{\%} vs 32{\%} in the standard care group (P=0.025). Cardiac death occurred in 15 patients, nine patients in the standard care and in six in the bisoprolol group; myocardial infarction occurred in six patients, five in the standard care and one in the bisoprolol group. The odds ratio for cardiac death or myocardial infarction after surgery in high-risk patients with additional bisoprolol therapy was 0.30 (0.11-0.83). Conclusions: Bisoprolol significantly reduced long-term cardiac death and myocardial infarction in high-risk patients after successful major cardiac vascular surgery.",
keywords = "Beta-blockers, High-risk patients, Long-term follow-up, Major vascular surgery",
author = "Don Poldermans and E. Boersma and Bax, {J. J.} and Thomson, {I. R.} and B. Paelinck and {Van De Ven}, {L. L M} and Scheffer, {M. G.} and G. Trocino and C. Vigna and Baars, {H. F.} and {Van Urk}, H. and Roelandt, {J. R T C}",
year = "2001",
doi = "10.1053/euhj.2000.2555",
language = "English",
volume = "22",
pages = "1353--1358",
journal = "European Heart Journal",
issn = "0195-668X",
publisher = "Oxford University Press",
number = "15",

}

TY - JOUR

T1 - Bisoprolol reduces cardiac death and myocardial infarction in high-risk patients as long as 2 years after successful major vascular surgery

AU - Poldermans, Don

AU - Boersma, E.

AU - Bax, J. J.

AU - Thomson, I. R.

AU - Paelinck, B.

AU - Van De Ven, L. L M

AU - Scheffer, M. G.

AU - Trocino, G.

AU - Vigna, C.

AU - Baars, H. F.

AU - Van Urk, H.

AU - Roelandt, J. R T C

PY - 2001

Y1 - 2001

N2 - Aim: To assess the long-term cardioprotective effect of bisoprolol in a randomized high-risk population after successful major vascular surgery. High-risk patients were defined by the presence of one or more cardiac risk factor(s) and a dobutamine echocardiography test positive for ischaemia. Methods: 1351 patients were screened prior to surgery, 846 patients had one or more risk factor(s), and 173 of these patients also had ischaemia during dobutamine echocardiography. One hundred and twelve patients could be randomized for additional bisoprolol therapy or standard care. Eleven patients died in the peri-operative period (up to 1 month after surgery). Randomized patients continued bisoprolol or standard care after surgery. During follow-up of 101 survivors (median 22 months, range 11-30) cardiac death or myocardial infarction was noted. No patient was lost during follow-up. Results: The incidence of cardiac events during follow-up in the bisoprolol group was 12% vs 32% in the standard care group (P=0.025). Cardiac death occurred in 15 patients, nine patients in the standard care and in six in the bisoprolol group; myocardial infarction occurred in six patients, five in the standard care and one in the bisoprolol group. The odds ratio for cardiac death or myocardial infarction after surgery in high-risk patients with additional bisoprolol therapy was 0.30 (0.11-0.83). Conclusions: Bisoprolol significantly reduced long-term cardiac death and myocardial infarction in high-risk patients after successful major cardiac vascular surgery.

AB - Aim: To assess the long-term cardioprotective effect of bisoprolol in a randomized high-risk population after successful major vascular surgery. High-risk patients were defined by the presence of one or more cardiac risk factor(s) and a dobutamine echocardiography test positive for ischaemia. Methods: 1351 patients were screened prior to surgery, 846 patients had one or more risk factor(s), and 173 of these patients also had ischaemia during dobutamine echocardiography. One hundred and twelve patients could be randomized for additional bisoprolol therapy or standard care. Eleven patients died in the peri-operative period (up to 1 month after surgery). Randomized patients continued bisoprolol or standard care after surgery. During follow-up of 101 survivors (median 22 months, range 11-30) cardiac death or myocardial infarction was noted. No patient was lost during follow-up. Results: The incidence of cardiac events during follow-up in the bisoprolol group was 12% vs 32% in the standard care group (P=0.025). Cardiac death occurred in 15 patients, nine patients in the standard care and in six in the bisoprolol group; myocardial infarction occurred in six patients, five in the standard care and one in the bisoprolol group. The odds ratio for cardiac death or myocardial infarction after surgery in high-risk patients with additional bisoprolol therapy was 0.30 (0.11-0.83). Conclusions: Bisoprolol significantly reduced long-term cardiac death and myocardial infarction in high-risk patients after successful major cardiac vascular surgery.

KW - Beta-blockers

KW - High-risk patients

KW - Long-term follow-up

KW - Major vascular surgery

UR - http://www.scopus.com/inward/record.url?scp=0034898333&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034898333&partnerID=8YFLogxK

U2 - 10.1053/euhj.2000.2555

DO - 10.1053/euhj.2000.2555

M3 - Article

VL - 22

SP - 1353

EP - 1358

JO - European Heart Journal

JF - European Heart Journal

SN - 0195-668X

IS - 15

ER -